SEP 09, 2020 10:00 AM PDT

Immunoprotective vs. immunopathogenic responses during fungal-associated allergic airway inflammation

Speaker

Abstract

Asthma is an increasing health concern affecting more than 25 million individuals in the United States and more than 300 million individuals worldwide. In some cases, sensitization or exposure to specific microbes can exacerbate asthma. In 2006, a new asthma phenotype termed “severe asthma with fungal sensitization” (SAFS) was described for individuals whose asthma was poorly-controlled and who were sensitized to fungi. We have previously reported that asthmatics sensitized to fungi demonstrate worse lung function, higher serum IgE, blood eosinophil and exhaled nitric oxide levels. A growing area of interest is the identification of factors that contribute to immunopathogenesis in allergic asthma, including those sensitized to fungi, and determining whether these could be viable therapeutic targets. Indeed, biologics targeting the type 2 cytokines IL-4, IL-5 and IL-13 have been successful in treating individuals with severe asthma. To this end, we have reported that human asthmatics sensitized to fungi have increased levels of multiple cytokines, chemokines and growth factors in bronchoalveolar lavage fluid and sputum, some of which correlate with lung function or atopic measurements. This presentation will provide an overview of these findings and how some of these mediators mechanistically contribute to disease severity using an experimental animal model of fungal-associated allergic airway inflammation.

Learning Objectives:

1. To understand the clinical significance of allergic asthma as it relates to fungal sensitization

2. To understand experimental animal models as it relates to determining immunoprotective vs. immunopathogenic responses during fungal asthma


Show Resources
You May Also Like
JUL 19, 2022 8:00 AM PDT
JUL 19, 2022 8:00 AM PDT
Date: July 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Traditional liver perfusion procedures are difficult to perform and require extensive training, steady hands, and long-st...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JUN 28, 2022 6:45 AM PDT
JUN 28, 2022 6:45 AM PDT
Date: June 28, 2022 Time: 3:00pm (BST), 4:00pm (CET), 9:00am (CST), 7am (PST) Light-sheet microscopy is an extremely versatile imaging technique with a vast range of implementations that are...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
JUN 21, 2022 6:00 AM PDT
JUN 21, 2022 6:00 AM PDT
Date: June 21, 2022 Time: 6:00am (PDT), 9:00am (EDT), 3:00pm (CEST) The global understanding and practice of medicine is currently undergoing a revolutionary change. This shift to precision...
JAN 13, 2022 9:00 AM PST
C.E. CREDITS
JAN 13, 2022 9:00 AM PST
Date: January 13, 2022 Time: 09:00am (PST), 12:00pm (EST) Recently, the Infectious Disease Society of America released guidance on how to approach treatment of infections caused by multidrug...
Loading Comments...
Show Resources
Attendees